List of works - Tom Maishman

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

scientific article

A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy.

scientific article published on 29 November 2013

A review of the online prognositc model predict using the POSH cohort (women aged ≤40 years at breast cancer diagnosis).

scientific article published on 16 November 2015

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

scientific article published on 18 June 2018

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

scientific article

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation

scientific article

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

scientific article

Association analysis identifies 65 new breast cancer risk loci.

scientific article published on 23 October 2017

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

article by Xiang Shu et al published 1 October 2018 in International Journal of Epidemiology

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses

scientific article

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss ⬇️

scientific article

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study

scientific article published on 22 October 2013

Family history and outcome of young patients with breast cancer in the UK (POSH study).

scientific article published on 20 May 2015

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

scientific article published on 07 January 2020

Genetic testing in a cohort of young patients with HER2-amplified breast cancer

scientific article

Genome-wide association study of germline variants and breast cancer-specific mortality

scientific article published on 21 February 2019

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women

scientific article published on 21 November 2017

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

scientific article published on 23 October 2017

Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study

scientific article published on 22 July 2016

Obesity and the outcome of young breast cancer patients in the UK: the POSH study

scientific article published on 30 October 2014

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

scientific article published on 10 June 2016

Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.

scientific article published on 19 July 2016

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

scientific article

ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer

scientific article

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study

scientific article published on 30 May 2013

Reply to 'Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses''

Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD.

scientific article

Understanding of BRCA VUS genetic results by breast cancer specialists

scientific article

Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial.

scientific article published on 8 September 2017

Wilms’ tumour antigen 1 Immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation: a Phase II non-randomised clinical trial (WIN)

scientific article

List of works by Tom Maishman

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy.

A review of the online prognositc model predict using the POSH cohort (women aged ≤40 years at breast cancer diagnosis).

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Association analysis identifies 65 new breast cancer risk loci.

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss ⬇️

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study

Family history and outcome of young patients with breast cancer in the UK (POSH study).

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Genetic testing in a cohort of young patients with HER2-amplified breast cancer

Genome-wide association study of germline variants and breast cancer-specific mortality

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study

Obesity and the outcome of young breast cancer patients in the UK: the POSH study

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study

Reply to 'Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses''

Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD.

Understanding of BRCA VUS genetic results by breast cancer specialists

Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial.

Wilms’ tumour antigen 1 Immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation: a Phase II non-randomised clinical trial (WIN)